• Go to navigation
  • Go to content
Atacand International

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca

Main navigation

  • Home
  • Prescribing Information
  • Mode of Action
  • Contact Us

You are here

  • Home
  • Atacand (candesartan cilexetil)

Atacand (candesartan cilexetil) is an angiotensin receptor blocker (ARB), indicated for the treatment of patients with hypertension and patients with chronic heart failure(CHF) and left ventricular systolic dysfunction.

Atacand Plus

Atacand Plus (candesartan cilexetil/hydrochlorothiazide) is a fixed combination of Atacand and the diuretic hydrochlorothiazide (HCTZ), indicated for the treatment of hypertension in patients who need more than monotherapy.

Did you know?

AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.

  • Healthcare professionals
  • Patients and families

Links to country-specific websites can be found using the AstraZeneca websites list.

If you still have a question regarding our drug portfolio you can Contact us.

Page tools

  • Print
  • Bookmark this page

Information

This website has been produced in accordance with both the ABPI Code of Practice for the Pharmaceutical Industry 2008 and the EFPIA Code on the Promotion of Prescription-only Medicines to, and interactions with, Healthcare Professionals.

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010